Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
An introductory note on why early financial planning matters for young adults, with initial steps to start building a solid plan.
23,940 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investors are debating whether Palantir stock can still deliver. This guide breaks down the growth story, the risks, ...
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
As Home Depot gears up to report, investors weigh EPS targets, margin dynamics, and housing trends. This guide breaks...
A security breach at a leading crypto gift card platform on March 1 has security researchers weighing North Korean-li...
A niche tech stock tied to crypto and forecasting markets surged today, driven by fresh funding and upbeat sentiment ...
A major move by Qualcomm leadership could alter the stock's trajectory. This article breaks down the implications, pr...
Cerebras stock priced at a premium can be tough for everyday investors. This guide shows how an AI-focused ETF offers...
A bold move to inoculate Bitcoin's price path has sparked debate among traders. This article unpacks what such a stra...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...
As SpaceX eyes a historic IPO, the idea of jamie dimon giving spacex turning the pitch gains traction. Here’s what th...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...